Shift the narrative. Unlock the potential.
The planetary hub for individuals, practitioners, and professionals exploring psychedelics.
The Latest
Weekly Psychedelic Policy Briefing: September 30th, 2026
DEA proposed placing five tryptamines in Schedule I, including the active compound in a postpartum depression drug FDA designated a breakthrough therapy in February. Oregon dropped its psilocybin fee hikes, and a GAO audit found DEA and FDA have no written procedures for how scheduling decisions get made.
By: Jack Gorsline
Podcasts
Browse All Podcasts
Rachel Turetzky, PhD & Douglas S. Wingate, DTCM: The Eight-Circuit Model, Metaprogramming, and Psychedelic Therapy
Drs. Rachel Turetzky and Douglas Wingate join Joe Moore and Kyle Buller to explore the…
Mike Finoia – The Comedy of Conscious Aging, Episode 16
Mike Finoia is a comedian based out of NYC. He is a writer/producer for TruTV’s Impractical…
Travis Tyler Fluck: Denver Mushroom Decriminalization, Mutual Aid, and the Future of Psychedelic Culture
Travis Tyler Fluck joins Joe Moore to discuss Denver mushroom decriminalization, the legacy of Initiative…
Articles
Browse All Articles
Weekly Psychedelic Policy Briefing, September 21, 2026
The FDA heard 80 speakers on the future of psychedelic drugs, and its federal panel…
By Jack Gorsline
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Optimi Health has Health Canada authorization for a Phase 2 trial of natural psilocybin in…
By Jack Gorsline
What Lynn Watkins Actually Told the FDA about Chronic Pain and Psychedelics
Reuters attributed a quote about access and reimbursement to Lynn Watkins at Monday’s FDA hearing…
By Joe Moore
Events
Browse All Events
Horizons: Perspectives on Psychedelics
Please join us this autumn for the 19th Horizons conference on October 15-17 in New…
The Vital Conference: Breckenridge 2026
New perspectives for your practice. Real connections with your peers. Join Psychedelics Today for two…
Education Center
Dive into courses exploring physiological, spiritual, and practical facets of psychedelic and holotropic states, designed to add value for all levels of psychedelic experience.
Visit our Psychedelic Education Center
More from Psychedelics Today
The Psychedelic Channel
Watch in-depth discussions with industry-leading experts on YouTube.
Visit our YouTube
Vital Psychedelic Training
Join a community of professionals on their mission to provide safe, ethical, and effective psychedelic treatment and integration. You’ll gain mastery in the elements of psychedelic practice in this 12-month accreditation program.
Visit Vital to Get Certified